---
document_datetime: 2025-12-02 05:24:23
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/daliresp.html
document_name: daliresp.html
version: success
processing_time: 0.1238479
conversion_datetime: 2025-12-26 17:46:23.77712
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Daliresp

[RSS](/en/individual-human-medicine.xml/66828)

##### Withdrawn

This medicine's authorisation has been withdrawn

roflumilast Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 11 January 2018, the European Commission withdrew the marketing authorisation for Daliresp (roflumilast) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, AstraZeneca AB, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Daliresp was granted marketing authorisation in the EU on 28 February 2011 for treatment of chronic obstructive pulmonary disease (COPD). The marketing authorisation was initially valid for a 5-year period. It was subsequently renewed for an additional 5-year period.

Daliresp was a duplicate of Daxas, which is marketed in several EU countries. The marketing authorisation holder will maintain the marketing authorisation for Daxas.

The European Public Assessment Report (EPAR) for Daliresp is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Daliresp : EPAR - Summary for the public

Reference Number: EMA/CHMP/220794/2013

English (EN) (546.08 KB - PDF)

**First published:** 11/03/2011

**Last updated:** 06/02/2018

[View](/en/documents/overview/daliresp-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-951)

български (BG) (633.14 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/bg/documents/overview/daliresp-epar-summary-public_bg.pdf)

español (ES) (552.45 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/es/documents/overview/daliresp-epar-summary-public_es.pdf)

čeština (CS) (613.17 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/cs/documents/overview/daliresp-epar-summary-public_cs.pdf)

dansk (DA) (549.93 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/da/documents/overview/daliresp-epar-summary-public_da.pdf)

Deutsch (DE) (572.1 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/de/documents/overview/daliresp-epar-summary-public_de.pdf)

eesti keel (ET) (548.29 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/et/documents/overview/daliresp-epar-summary-public_et.pdf)

ελληνικά (EL) (636.5 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/el/documents/overview/daliresp-epar-summary-public_el.pdf)

français (FR) (549.53 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/fr/documents/overview/daliresp-epar-summary-public_fr.pdf)

hrvatski (HR) (570.52 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/hr/documents/overview/daliresp-epar-summary-public_hr.pdf)

italiano (IT) (550.18 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/it/documents/overview/daliresp-epar-summary-public_it.pdf)

latviešu valoda (LV) (611.23 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/lv/documents/overview/daliresp-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (573.08 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/lt/documents/overview/daliresp-epar-summary-public_lt.pdf)

magyar (HU) (603.91 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/hu/documents/overview/daliresp-epar-summary-public_hu.pdf)

Malti (MT) (615.35 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/mt/documents/overview/daliresp-epar-summary-public_mt.pdf)

Nederlands (NL) (551.25 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/nl/documents/overview/daliresp-epar-summary-public_nl.pdf)

polski (PL) (613.23 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/pl/documents/overview/daliresp-epar-summary-public_pl.pdf)

português (PT) (551.5 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/pt/documents/overview/daliresp-epar-summary-public_pt.pdf)

română (RO) (571.82 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/ro/documents/overview/daliresp-epar-summary-public_ro.pdf)

slovenčina (SK) (612.85 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/sk/documents/overview/daliresp-epar-summary-public_sk.pdf)

slovenščina (SL) (605.35 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/sl/documents/overview/daliresp-epar-summary-public_sl.pdf)

Suomi (FI) (545.15 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/fi/documents/overview/daliresp-epar-summary-public_fi.pdf)

svenska (SV) (550.63 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/sv/documents/overview/daliresp-epar-summary-public_sv.pdf)

## Product information

Daliresp : EPAR - Product Information

English (EN) (774.28 KB - PDF)

**First published:** 11/03/2011

**Last updated:** 06/02/2018

[View](/en/documents/product-information/daliresp-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-362)

български (BG) (1.33 MB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/bg/documents/product-information/daliresp-epar-product-information_bg.pdf)

español (ES) (788.7 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/es/documents/product-information/daliresp-epar-product-information_es.pdf)

čeština (CS) (1.13 MB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/cs/documents/product-information/daliresp-epar-product-information_cs.pdf)

dansk (DA) (794.29 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/da/documents/product-information/daliresp-epar-product-information_da.pdf)

Deutsch (DE) (800.88 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/de/documents/product-information/daliresp-epar-product-information_de.pdf)

eesti keel (ET) (776.19 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/et/documents/product-information/daliresp-epar-product-information_et.pdf)

ελληνικά (EL) (1.42 MB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/el/documents/product-information/daliresp-epar-product-information_el.pdf)

français (FR) (804.59 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/fr/documents/product-information/daliresp-epar-product-information_fr.pdf)

hrvatski (HR) (794.74 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/hr/documents/product-information/daliresp-epar-product-information_hr.pdf)

íslenska (IS) (785.55 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/is/documents/product-information/daliresp-epar-product-information_is.pdf)

italiano (IT) (796.63 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/it/documents/product-information/daliresp-epar-product-information_it.pdf)

latviešu valoda (LV) (1.16 MB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/lv/documents/product-information/daliresp-epar-product-information_lv.pdf)

lietuvių kalba (LT) (780.52 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/lt/documents/product-information/daliresp-epar-product-information_lt.pdf)

magyar (HU) (1.14 MB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/hu/documents/product-information/daliresp-epar-product-information_hu.pdf)

Malti (MT) (1.19 MB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/mt/documents/product-information/daliresp-epar-product-information_mt.pdf)

Nederlands (NL) (798.54 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/nl/documents/product-information/daliresp-epar-product-information_nl.pdf)

norsk (NO) (774.52 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/no/documents/product-information/daliresp-epar-product-information_no.pdf)

polski (PL) (1.17 MB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/pl/documents/product-information/daliresp-epar-product-information_pl.pdf)

português (PT) (788.24 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/pt/documents/product-information/daliresp-epar-product-information_pt.pdf)

română (RO) (795.79 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/ro/documents/product-information/daliresp-epar-product-information_ro.pdf)

slovenčina (SK) (1.13 MB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/sk/documents/product-information/daliresp-epar-product-information_sk.pdf)

slovenščina (SL) (1.1 MB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/sl/documents/product-information/daliresp-epar-product-information_sl.pdf)

Suomi (FI) (777.71 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/fi/documents/product-information/daliresp-epar-product-information_fi.pdf)

svenska (SV) (787.97 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/sv/documents/product-information/daliresp-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** T/0030 03/11/2016

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Daliresp : EPAR - All Authorised presentations

English (EN) (486.93 KB - PDF)

**First published:** 11/03/2011

**Last updated:** 06/02/2018

[View](/en/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-596)

български (BG) (538.13 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/bg/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_bg.pdf)

español (ES) (487.32 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/es/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_es.pdf)

čeština (CS) (505.6 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/cs/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (480.29 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/da/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (487.21 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/de/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (480.16 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/et/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (540.08 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/el/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_el.pdf)

français (FR) (480.24 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/fr/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (493.49 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/hr/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (489.44 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/is/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_is.pdf)

italiano (IT) (486.97 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/it/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (529.57 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/lv/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (514.61 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/lt/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (521.56 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/hu/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (530.12 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/mt/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (479.01 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/nl/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (485.33 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/no/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_no.pdf)

polski (PL) (506.02 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/pl/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_pl.pdf)

português (PT) (487.73 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/pt/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_pt.pdf)

română (RO) (515.38 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/ro/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (522.74 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/sk/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (491.74 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/sl/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (481.73 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/fi/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (487.3 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/sv/documents/all-authorised-presentations/daliresp-epar-all-authorised-presentations_sv.pdf)

Daliresp : EPAR - Conditions imposed on member states for safe and effective use - Annex IV

English (EN) (576.76 KB - PDF)

**First published:** 11/03/2011

**Last updated:** 06/02/2018

[View](/en/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_en.pdf)

[Other languages (23)](#file-language-dropdown-611)

български (BG) (676.9 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/bg/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_bg.pdf)

español (ES) (583.13 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/es/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_es.pdf)

čeština (CS) (650.55 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/cs/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_cs.pdf)

dansk (DA) (585.1 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/da/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_da.pdf)

Deutsch (DE) (579.06 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/de/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_de.pdf)

eesti keel (ET) (584.62 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/et/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_et.pdf)

ελληνικά (EL) (682.29 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/el/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_el.pdf)

français (FR) (582.02 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/fr/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_fr.pdf)

íslenska (IS) (571.86 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/is/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_is.pdf)

italiano (IT) (576 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/it/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_it.pdf)

latviešu valoda (LV) (646.43 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/lv/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_lv.pdf)

lietuvių kalba (LT) (606.07 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/lt/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_lt.pdf)

magyar (HU) (634.99 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/hu/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_hu.pdf)

Malti (MT) (627.75 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/mt/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_mt.pdf)

Nederlands (NL) (575.84 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/nl/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_nl.pdf)

norsk (NO) (583.22 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/no/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_no.pdf)

polski (PL) (658.51 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/pl/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_pl.pdf)

português (PT) (573.75 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/pt/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_pt.pdf)

română (RO) (603.02 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/ro/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_ro.pdf)

slovenčina (SK) (642.65 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/sk/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sk.pdf)

slovenščina (SL) (630.83 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/sl/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sl.pdf)

Suomi (FI) (580.37 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/fi/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_fi.pdf)

svenska (SV) (583.1 KB - PDF)

**First published:**

11/03/2011

**Last updated:**

06/02/2018

[View](/sv/documents/conditions-member-states/daliresp-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sv.pdf)

## Product details

Name of medicine Daliresp Active substance roflumilast International non-proprietary name (INN) or common name roflumilast Therapeutic area (MeSH) Pulmonary Disease, Chronic Obstructive Anatomical therapeutic chemical (ATC) code R03DX07

### Pharmacotherapeutic group

Drugs for obstructive airway diseases

### Therapeutic indication

Daliresp is indicated for maintenance treatment of severe chronic obstructive pulmonary disease (COPD) (FEV1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis in adult patients with a history of frequent exacerbations as add-on to bronchodilator treatment.

## Authorisation details

EMA product number EMEA/H/C/002398 Marketing authorisation holder

AstraZeneca AB

151 85 Sodertalje

Marketing authorisation issued 28/02/2011 Withdrawal of marketing authorisation 11/01/2018 Revision 9

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Daliresp : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (625.79 KB - PDF)

**First published:** 15/06/2011

**Last updated:** 06/02/2018

[View](/en/documents/procedural-steps-after/daliresp-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Daliresp-H-C-PSUSA-00002658-201407 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Reference Number: EMA/CHMP/117044/2015

English (EN) (524.26 KB - PDF)

**First published:** 20/04/2015

**Last updated:** 06/02/2018

[View](/en/documents/scientific-conclusion/daliresp-h-c-psusa-00002658-201407-epar-scientific-conclusions-and-grounds-recommending-variation-terms-marketing-authorisation_en.pdf)

## Initial marketing authorisation documents

Daliresp : EPAR - Public assessment report

Adopted

English (EN) (661.75 KB - PDF)

**First published:** 11/03/2011

**Last updated:** 06/02/2018

[View](/en/documents/assessment-report/daliresp-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Daliresp

Adopted

Reference Number: EMA/CHMP/825394/2010

English (EN) (508.05 KB - PDF)

**First published:** 17/12/2010

**Last updated:** 06/02/2018

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-daliresp_en.pdf)

**This page was last updated on** 06/02/2018

## Share this page

[Back to top](#main-content)